436 related articles for article (PubMed ID: 19056198)
1. Identification, isolation and characterization of process-related impurities in Rizatriptan benzoate.
Raj TJ; Bharathi Ch; Kumar MS; Prabahar J; Kumar PN; Sharma HK; Parikh K
J Pharm Biomed Anal; 2009 Jan; 49(1):156-62. PubMed ID: 19056198
[TBL] [Abstract][Full Text] [Related]
2. Structural elucidation of impurities in 5-n-butyl-4-{4-[2-(1H-tetrazole-5-yl)-1H-pyrrol-1-yl]phenylmethyl}-2,4-dihydro-2-(2,6-dichlorophenyl)-3H-1,2,4-triazol-3-one (Ib), a novel nonpeptide angiotensin AT1 receptor antagonist.
Gao T; Liu Y; Ji Y; Wu X; Xu J
J Pharm Biomed Anal; 2012 Jul; 66():381-6. PubMed ID: 22516679
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of potential impurities of valsartan, AT1 receptor antagonist.
Sampath A; Reddy AR; Yakambaram B; Thirupathi A; Prabhakar M; Reddy PP; Reddy VP
J Pharm Biomed Anal; 2009 Oct; 50(3):405-12. PubMed ID: 19560892
[TBL] [Abstract][Full Text] [Related]
4. Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate.
Bharathi Ch; Prabahar KJ; Prasad ChS; Srinivasa Rao M; Trinadhachary GN; Handa VK; Dandala R; Naidu A
Pharmazie; 2008 Jan; 63(1):14-9. PubMed ID: 18271296
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of some potential impurities in ropinirole hydrochloride.
Sahasrabuddhey B; Nautiyal R; Acharya H; Khyade S; Luthra PK; Deshpande PB
J Pharm Biomed Anal; 2007 Mar; 43(4):1587-93. PubMed ID: 17207602
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of degradation products of dicloxacillin in bulk drug and pharmaceutical dosage forms.
Raj TJ; Bharati CH; Rao KR; Rao PS; Narayan GK; Parikh K
J Pharm Biomed Anal; 2007 Mar; 43(4):1470-5. PubMed ID: 17125952
[TBL] [Abstract][Full Text] [Related]
7. Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium.
Saravanan M; Siva Kumari K; Pratap Reddy P; Naidu MN; Moses Babu J; Srivastava AK; Lakshmi Kumar T; Chandra Sekhar BV; Satyanarayana B
J Pharm Biomed Anal; 2008 Nov; 48(3):708-15. PubMed ID: 18755563
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of new impurities in rivastigmine.
Srinivasa Rao M; Rao SV; Srinivasa Rao DV; Bharathi Ch; Rajput P; Sharma HK
Pharmazie; 2010 May; 65(5):336-8. PubMed ID: 20503924
[TBL] [Abstract][Full Text] [Related]
9. Isolation, structural elucidation and characterization of impurities in Cefdinir.
Rao KV; Rani A; Reddy AV; Bharathi CH; Dandala R; Naidu A
J Pharm Biomed Anal; 2007 Mar; 43(4):1476-82. PubMed ID: 17174507
[TBL] [Abstract][Full Text] [Related]
10. Identification, preparation and UHPLC determination of process-related impurity in zolmitriptan.
Douša M; Gibala P; Rádl S; Klecán O; Mandelová Z; Břicháč J; Pekárek T
J Pharm Biomed Anal; 2012 Jan; 58():1-6. PubMed ID: 21982522
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of new impurity in didanosine.
Srinivasa Rao DV; Srinivas N; Bharathi Ch; Prasad ChS; Dandala R; Naidu A
J Pharm Biomed Anal; 2007 Nov; 45(3):516-20. PubMed ID: 17624711
[TBL] [Abstract][Full Text] [Related]
12. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
[TBL] [Abstract][Full Text] [Related]
13. Structural identification and characterization of impurities in moxifloxacin.
Kumar YR; Prasad Raju VV; Kumar RR; Eswaraiah S; Mukkanti K; Suryanarayana MV; Reddy MS
J Pharm Biomed Anal; 2004 Mar; 34(5):1125-9. PubMed ID: 15019047
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization of impurities in pioglitazone.
Kumar YR; Reddy AR; Eswaraiah S; Mukkanti K; Reddy MS; Suryanarayana MV
Pharmazie; 2004 Nov; 59(11):836-9. PubMed ID: 15587582
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a specific stability indicating high performance liquid chromatographic method for rizatriptan benzoate.
Mallikarjuna Rao B; Sangaraju S; Srinivasu MK; Madhavan P; Lalitha Devi M; Rajendra Kumar P; Chandrasekhar KB; Arpitha Ch; Satya Balaji T
J Pharm Biomed Anal; 2006 Jun; 41(4):1146-51. PubMed ID: 16563688
[TBL] [Abstract][Full Text] [Related]
16. Isolation and structural identification of an impurity in fluconazole bulk drug substance.
Dongre VG; Ghugare PD; Karmuse PP; Soudagar SR; Panda N; Kumar A
J Pharm Biomed Anal; 2007 Nov; 45(3):422-9. PubMed ID: 17706390
[TBL] [Abstract][Full Text] [Related]
17. Structural identification and characterization of impurities in ceftizoxime sodium.
Bharathi Ch; Prasad ChS; Bharathi DV; Shankar R; Rao VJ; Dandala R; Naidu A
J Pharm Biomed Anal; 2007 Jan; 43(2):733-40. PubMed ID: 16950586
[TBL] [Abstract][Full Text] [Related]
18. Preparative isolation and structural elucidation of impurities in fluconazole by LC/MS/MS.
Dongre VG; Karmuse PP; Ghugre PD; Salunke SM; Panda N; Kumar A
J Pharm Biomed Anal; 2006 Sep; 42(3):334-40. PubMed ID: 16757140
[TBL] [Abstract][Full Text] [Related]
19. Identification, isolation and characterization of potential degradation product in risperidone tablets.
Bharathi Ch; Chary DK; Kumar MS; Shankar R; Handa VK; Dandala R; Naidu A
J Pharm Biomed Anal; 2008 Jan; 46(1):165-9. PubMed ID: 17981421
[TBL] [Abstract][Full Text] [Related]
20. Isolation, synthesis and characterization of impurities in celecoxib, a COX-2 inhibitor.
Satyanarayana U; Rao DS; Kumar YR; Babu JM; Kumar PR; Reddy JT
J Pharm Biomed Anal; 2004 Jun; 35(4):951-7. PubMed ID: 15193741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]